Market dairy cows (n = 34) 
INTRODUCTION
Market cows across the country are culled for various reasons including health issues; reproductive failure; and, in dairy operations, loss of profitability due to a decrease in milk production or milk prices, increases in feed prices, and other costs. In 2008, cull cows accounted for almost 18% of all beef animals slaughtered, and the meat from market cows comprised about 14.5% of the beef produced in the United States (USDA-ERS, 2009) . In an effort to maximize income, some producers have begun to implement short-term preslaughter feeding programs to reduce discounts for light carcass weights and poor muscling of carcasses from cull cows.
Zilpaterol hydrochloride (ZH), a β 2 -adrenergic agonist commercially available as Zilmax (Intervet/Schering-Plough Animal Health, Millsboro, DE), repartitions nutrients toward lean accretion. Label claims for Zilmax indicate its ability to improve animal performance and yield characteristics in fed heifers while having no adverse effects on marbling and s.c. fat. Supplementation with ZH has been shown to improve carcass yields and cutability in fed cattle (Boler et al., 2009; Shook et al., 2009) and fed cows (Neill et al., 2009; Lawrence et al., 2011) . Inclusion of Zilmax in a short-term feeding regimen may be a way to increase the value of carcasses from market dairy cows through increased muscling and subprimal cut yields.
Furthermore, short-term feeding may also have animal welfare benefits, particularly with regard to animal mobility. Inadequate muscling, poor BCS, and lameness can reduce carcass weight, price, and profit derived from
The Professional Animal Scientist 28 ( 2012 ):150-157 T he effects of zilpaterol hydrochloride supplementation on market dairy cow performance, carcass characteristics, and cutability market cows (Roeber et al., 2001 ). This improved mobility could result in fewer problems during transportation and movement to slaughter and reduce consumer concerns over the welfare of market cows. Therefore, the objective of this experiment was to evaluate the effect of a short-term feeding regimen, with or without ZH, on market dairy cow welfare, performance, carcass traits, and primal and subprimal yields.
MATERIALS AND METHODS

Cattle and Dietary Treatments
All animal use and handling techniques described herein were approved by the University of Georgia Animal Care and Use Committee. Cull dairy cows (initial BW of 625 ± 155.1 kg), of predominantly Holstein breeding, were used in this study to investigate the effects of ZH supplementation on animal mobility, feedlot performance, carcass yield and quality traits, and primal, subprimal, and select value cut yields. Cows were purchased from 2 dairies (one in northeast Georgia and one in southwest South Carolina) and transported less than 70 km to the study site. Upon arrival at the University of Georgia Wilkins Beef Unit in Rayle, Georgia, cows were treated with an orally administered anthelmintic (Safe-Guard, 10% fenbendazole, 5 mg/kg of BW, Intervet/ Schering-Plough), a 7-way clostridia vaccine (Vision 7 with SPUR, 2 mL, Intervet/Schering-Plough), a broadspectrum respiratory vaccine (Vista 5 L5 SQ, 2 mL, Intervet ScheringPlough) and weighed and ear tagged for identification. Cows were held on pasture (native bermudagrass) during a quarantine period (21 d) to assess any serious issues that might hinder their performance in the study, such as lameness or health problems.
Cows (n = 34) that were deemed acceptable for the study (showing no critical problems with structure or mobility) were stratified by BW (heaviest to lightest) and randomly assigned to 2 treatments: 1) a concentrate diet for 42 d (control) or 2) a concentrate diet for 42 d with supplementation of ZH (Zilmax) from d 19 to 39 followed by a 3-d withdrawal. Cows were implanted in the left ear with a growth-promoting implant containing 200 mg of trenbolone acetate and 20 mg of estradiol (Revalor-200, Intervet/Schering-Plough) on d −7. At the same time as implantation, cows were fitted with radio control collars for use with a Calan Broadbent Feeding System (American Calan, Northwood, NH). The gates were left open, and cows were allowed free access to the control diet. On d −4, the gates were closed to familiarize the cows to the gate system. After observation, all cows were familiarized with the gates and were able to operate them efficiently.
The ingredients and chemical composition of the diets can be found in Table 1 . Zilmax was received as a pelleted premix that contained 352 mg of ZH per kilogram of pelleted wheat middlings. The premix was added to the diet at the rate of 2.12%, which resulted in 8.33 mg/kg of active ingredient (100% DM basis) in the final diet. The feed and premix were mixed with a Calan Data Ranger (American Calan; 5 min) and fed in a Calan Broadbent Feeding System (American Calan). Cows not receiving ZH received additional pelleted wheat middlings at the rate of 2.12% mixed into the diet. Feed analysis (conducted weekly) showed that ZH levels were within acceptable limits for the zilpaterol diet and that no ZH was present in the control diet. Feed refusal was measured weekly and feed intake calculated.
Live-animal data collection included locomotion scoring, BCS, BW, and ultrasound measurements taken on d 0, 19, and 42. For locomotion score, a 5-point-scale locomotion scoring system was used (1 = normal or no signs of lameness and 5 = severely lame; Sprecher et al., 1997; Zinpro Performance Minerals, Eden Prairie, MN) . A 5-point scale with half-point increments was used for BCS (1 = extremely emaciated and 5 = extremely overconditioned; Wildman et 
Slaughter and Grading
At the conclusion of feeding, cows were transported (43.6 km) to the University of Georgia Meat Science and Technology Center in Athens, where they were held (16 h) and allowed free access to water before slaughter. Cows were slaughtered under inspection, according to industry standards. Slaughter weights and HCW were collected. After a chill period (−2°C) of 48 h, carcasses were ribbed at the 12th-13th rib juncture, and USDA YG and QG data were gathered, including 12th-rib fat thickness, LM area, KPH as a percentage of carcass weight, maturity, and marbling score along with pH (Oakton pH 11 Series, Oakton Instruments, Vernon Hills, IL) taken on the 12th rib face of the LM. In addition, Hunter L*, a*, and b* values (Hunter Miniscan XE Plus Spectrophotometer, Model 45/0 LAV, 2.54-cm-diameter aperture, 10° standard observer, D65 Illuminate, Hunter Associated Laboratories Inc., Reston, VA, calibrated to a white tile with known values) were collected on the 12th-rib lean surface, and s.c. fat color was measured in the 10th to 12th rib region of the carcass approximately 15 cm off the midline. Fat color was also measured subjectively on a 5-point scale, where 1 = white and 5 = dark yellow.
Carcass Fabrication and Yield
Left sides were fabricated into primals, subprimals, and boneless closely trimmed cuts according to the guidelines of the North American Meat Processors Association (NAMP, 2007) . Chilled side weights were recorded before fabrication. For final product weights, fat was trimmed to 0.64 cm.
The forequarter and hindquarter were separated between the 12th and 13th rib, and the rib and plate were then separated from the chuck and brisket by a straight cut between the 5th and 6th ribs perpendicular to the long axis of the carcass. The chuck and brisket were further fabricated into the NAMP #114 shoulder clod, NAMP #120 whole brisket, and NAMP #116A chuck roll. The NAMP #114 shoulder clod was fabricated to yield a NAMP #114D top blade, a NAMP #114F shoulder tender (teres major), and a NAMP #114E arm roast, which was later divided into the shoulder top (triceps brachii lateral head) and the shoulder center (triceps brachii long head). The NAMP #120 whole brisket was fabricated to yield the NAMP #120A brisket flat. The NAMP #103 rib primal was separated from the plate and fabricated into an NAMP #112A boneless ribeye roll.
The NAMP #172 primal loin was fabricated to yield the NAMP #189A full tenderloin, NAMP #175 strip loin bone-in, and NAMP #181 sirloin. The NAMP #175 strip loin bone-in was fabricated to yield the NAMP #180 boneless strip loin, and the NAMP #181 sirloin was fabricated to yield the NAMP #184 boneless top sirloin. The NAMP #158 round primal was fabricated into the NAMP #168 top round, NAMP #170 bottom round (gooseneck), and NAMP #167 knuckle (tip). The NAMP #168 top round was fabricated to the NAMP #169D top round, side off, cap off. The NAMP #170 bottom round was fabricated to yield the NAMP #171B outside flat and the NAMP #171C eye round. The NAMP #167 knuckle was fabricated into the NAMP #167A peeled knuckle, which was divided into the NAMP #167E tip center (rectus femoris) and the NAMP #167F tip side (vastus lateralis).
Statistical Analysis
Data were analyzed using the MIXED procedures of SAS (SAS Institute Inc., Cary, NC), and means separation was accomplished by the PDIFF option. For all parameters measured, animal (n = 34) served as the experimental unit with treatment (control or zilpaterol) serving as the fixed effect in the model. For growth performance and ultrasound evaluations, data were analyzed as repeated measures, with animal as the subject and the appropriate covariate structure; animal served as the experimental unit, with the treatment, day of study, and their interaction serving as fixed effects. Comparisons at each time point measured were generated by the use of contrast statements in SAS. Differences were considered significant at P < 0.05.
RESULTS AND DISCUSSION
Growth Performance
Zilpaterol supplementation had no effect (P > 0.05) on locomotion score, BCS, or BW over the course of the feeding period (Table 2) . Lameness in United States market dairy cows is a common and persistent problem, based on evidence that 49% of dairy cows evaluated immediately before slaughter were classified as lame (NCBA, 2007) . Lameness can result in increased trim loss and decreased saleable product (NCBA, 2007) as well as negative effects on consumers' perception of animal welfare. Allen et al. (2009) conducted a 90-d feeding trial with market dairy cows and concluded that after removing the physiological stress of lactation and the physical stress of walking to the milking parlor several times daily, an improvement in locomotion score was observed. In agreement with these findings, market dairy cows in this study showed improved locomotion scores (fewer signs of lameness) as time on feed increased, although differences were not significant between treatments. It is important to note that the cows in this study did not present any serious issues with structure or lameness at the start of the study and were left with only little opportunity for improvement. Although BCS was unaffected in this study, Schnell et al. (1997) and Allen et al. (2009) reported increases in BCS after 28 and 90 d on feed, respectively, for market dairy cows. Cattle producers recognize the significance of external fatness, or body condition, and the importance it has when determining cowherd fertility, productivity, and profitability (Dziuk and Bellows, 1983; Richards et al., 1986) .
Zilpaterol supplementation for the last 20 d of the 42-d feeding trial had no effect (P > 0.05) on growth performance of market dairy cows in this study. This included ADG for the final 23 d, overall ADG, G:F for the last 23 d, overall G:F, DMI for the last 23 d, and overall DMI (Table  2 ). Other studies have yielded inconsistent results when measuring the effects of zilpaterol supplementation on growth performance of cows. The present findings concur with those of Neill et al. (2009) , who reported no effects of zilpaterol supplementation on growth performance traits of market beef cows supplemented with zilpaterol for 30 d before slaughter. However, Lawrence et al. (2011) reported advantages of zilpaterol-fed cows when measuring BW gain, ADG, and G:F of finished cull cows concentrate fed and zilpaterol fed for 20 d before slaughter. Zilpaterol feeding has been consistently reported to improve growth performance traits such as BW gain, ADG, and G:F when evaluating the responses in finishing steers (Avendaño-Reyes et al., 2006; Elam et al., 2009; Montgomery et al., 2009) and heifers .
In regard to market dairy cows, Allen et al. (2009) reported no advantages in growth performance of market dairy cows fed ractopamine (RAC) for 32 d before slaughter when compared with control-fed cows. The data from the present study reflect similar results for DMI and G:F of market dairy cows fed before slaughter. It has been reported that large-framed dairy cows are at a disadvantage to moderate-sized beef cows for feed efficiency (Basarb et al., 2003) and that BW strongly influences feed efficiency because of the added feed needed to meet the additional maintenance requirements. Holmer et al. (2009) and Allen et al. (2009) concluded that no advantage of RAC treatment on market cow growth performance was observed due to extreme variability associated with feeding market beef and dairy cows, respectively. Additionally, Allen et al. (2009) reported that variation among performance traits measured is likely due to the large amount of variation in age, health status, genetic makeup, physiological stage of gestation or lactation, production history, and reason for removal from the lactating herd.
It is important to note that in the present study, the differences in BW between the control-fed and zilpaterol-fed cows were 15.1 and 13.8 kg at the beginning and end of the study, respectively. Although the differences in BW between treatments were not significant, it needs to be taken into consideration that the diets fed were not representative of a highenergy finishing diet commonly seen in studies evaluating zilpaterol and that the results presented may not be attributed solely to zilpaterol. The diets were formulated to be a costeffective approach to add extra value to market dairy cows, the carcasses from market dairy cows, or both. In agreement with Allen et al. (2009) , the variability seen in this study is not surprising because data from the National Market Cow and Bull Beef Quality Audit (NCBA, 2007) reported that the variation present is consistent with the variation present in the industry.
Ultrasound body composition measurements, over the course of the study, did not differ across treatment for ultrasound backfat during the last 23 d of the study; however, there was a treatment effect for both ultrasound LM area and UIMF (Table 3) . Both treatments had numerical increases in LM area; however, the zilpaterol-fed cows increased (P < 0.01) at a greater rate than did the control-fed cows. Ultrasound LM area for control-fed cows increased 3.13 cm 2 during the last 23 d of feeding, whereas the zilpaterolfed cows increased 8.40 cm 2 , indicating an advantage in nutrient deposition of the zilpaterol-fed cows over the control-fed cows. Similarly, UIMF percentages for both treatments numerically decreased over the feeding period; however, the zilpaterol-fed cows had a final UIMF that was less (0.51%; P = 0.03) than that of the control-fed cows, which is indicative of decreased marbling associated with zilpaterol supplementation (Beckett et al., 2009; Montgomery et al., 2009; Lawrence et al., 2011) .
Carcass Characteristics
Carcasses from zilpaterol-fed cows had greater (P = 0.02) dressing yield and increased (P < 0.01) LM area when compared with carcasses from control-fed cows (Table  4) . These changes in carcass traits also led to improved (P = 0.02) YG of carcasses of zilpaterol-fed cows when compared with those from control-fed cows. These findings are comparable to those of other reports of zilpaterol supplementation and the effects on dressing yield and LM area in finishing steers and heifers (Avendaño-Reyes et al., 2006; Vasconcelos et al., 2008; Elam et al., 2009; Montgomery et al., 2009) and in fed cows (Lawrence et al., 2011) . However, Neill et al. (2009) reported that zilpaterol feeding did not have an effect on yield-determining traits in market beef cows supplemented with zilpaterol for 30 d before slaughter. Similarly, no treatment effects on carcass weights, dressing yields, or LM area were reported when evaluating the effects of RAC supplementation in market beef cows (Dijkhuis et al., 2008; Holmer et al., 2009; Allen et al., 2009) and market dairy cows . The combined effect of reduced protein degradation and increased protein synthesis with β 2 -adrenergic agonists has been suggested as the reason for the significant increases generally noted in LM area . Yield grade was improved (3.0 vs. 2.4; P = 0.02) by zilpaterol supplementation in this study, primarily as a result of increased LM area. Although not significant, zilpaterol-fed cows had increased carcass weights, decreased fat thickness, and decreased KPH when compared with control-fed cows, which also contributed to the reductions in YG for zilpaterol-fed cows. The weights for carcasses from zilpaterol-fed cows were approximately 9 kg heavier than those from control-fed cows. Although the differences in carcass weights were not significant, the variability mentioned above with regard to BW needs to be considered and evaluated because the absence of a statistical difference may not be in relation to zilpaterol. The yield improvements reported in this study are substantial. An increase of 2.7% in the dressing percentage from zilpaterol-fed cows should result in increased profits if these cows are marketed on a value-based system, in addition to a traditional BW basis .
Zilpaterol supplementation did not have an effect (P ≥ 0.08) on any of the meat-quality characteristics measured, including maturity, marbling score, instrumental lean color, instrumental fat color, subjective fat color, or pH. The lack of zilpaterol effects on marbling scores in this study contradicts previous studies that reported decreases in marbling scores when steers Montgomery et al., 2009) and market beef cows (Lawrence et al., 2011) were supplemented with zilpaterol before slaughter. The findings in the present study are in agreement with those of Neill et al. (2009) , who reported that feeding zilpaterol to market beef cows before slaughter did not have an effect on marbling scores. The findings for lean color are consistent with other studies involving β-adrenergic agonist feeding in finishing steers (Avendaño-Reyes et al., 2006; Elam et al., 2009) and market cows (Dijkhuis et al., 2008; Allen et al., 2009; Neill et al., 2009) , although concentrate feeding alone has been shown to improve lean color scores when compared with nonfed cows (Boleman et al., 1996; Allen et al., 2009) .
Fat color is an increasingly important trait for beef consumers, and market cow packing plants are beginning to segregate cow carcasses with white fat into a premium category (NCBA, 2007) . Typical market cows are not fed concentrates, and many produce carcasses with a yellow, undesirable color because β-carotene accumulates in their s.c. fat as they graze. In this study, fat color was not influenced by zilpaterol supplementation. In other studies involving preslaughter feeding of cows, fat color has been improved with concentrate feeding for at least 42 d before slaughter (Stelzleni et al., 2007; Allen et al., 2009) .
Carcass Yields
Zilpaterol supplementation had significant effects on increasing primal, subprimal, and selected addedvalue cut yields of market dairy cow carcasses (Tables 5 and 6 ). In total, carcasses from zilpaterol-fed cows produced approximately 11 kg more primal weight and 5.5 kg more trimmed subprimal weight compared with carcasses from control-fed cows. These findings are similar to those of Boler et al. (2009) , who reported zilpaterol significantly increased subprimal weights and cutting yields in the round, loin/flank, rib/plate, and chuck of calf-fed Holstein steers. Additionally, Neill et al. (2009) and Lawrence et al. (2011) reported increases in subprimal weights for market beef cows supplemented with zilpaterol for 30 and 20 d before slaughter, respectively. However, Allen et al. (2009) reported no changes in strip loin, inside round, trim, and cutout weights of market dairy cows supplemented with RAC.
Increased yields in this study appear to be associated primarily with the increased muscling noted for ZH-fed dairy cows. In terms of value, the added weight of the carcasses from zilpaterol-fed cows resulted in a $42.34 advantage over those from control-fed cows based on June 19, 2009, prices from USDA Market News National Weekly Cutter Cow Cutout and Boxed Beef Cuts value report (report LM_XB461). After fabrication, the trimmed subprimals of carcasses from zilpaterol-fed cows were worth an additional $42.84, overall, compared with subprimals from carcasses of control-fed cows. When expressed as a percentage of chilled side weight, yields from carcasses of zilpaterol-fed cows were typically greater than those from control-fed cows. This became more evident as bone and fat were 4 QG codes: 5 = high Utility; 6 = low Commercial. 5 L* = a measure of darkness and lightness (higher value indicates a lighter color); a* = a measure of redness (higher value indicates a redder color); b* = a measure of yellowness (higher value indicates a more yellow color). 6 Fat color scale: 1 = bleached white; 5 = canary yellow.
trimmed from the subprimal and the weight represented muscle alone. This is consistent with the mode of action for zilpaterol, which increases protein synthesis and decreases protein degradation, causing significant protein accretion.
IMPLICATIONS
Zilpaterol supplementation to market dairy cows in this study resulted in carcasses with greater dressing yields, more muscling, and overall increased value when compared with carcasses from control-fed cows. The effects of zilpaterol in this study ultimately increased the overall value of carcasses from supplemented market dairy cows. Zilpaterol supplementation in market dairy cows has the potential to be a profitable practice if the carcasses are marketed on a valuebased marketing system rather than a live-weight basis. However, with most marketing strategies, other factors such as costs of inputs and time of marketing still have a great influence on overall potential profitability. The amount of research in the area of market dairy cows and preslaughter feeding, especially in relation to the use of zilpaterol, is limited and should be evaluated as an approach to increase returns from cull dairy cow receipts.
